139 related articles for article (PubMed ID: 29792312)
1. Identification of patients with hemoglobin SS/Sβ
Singh A; Mora J; Panepinto JA
Blood Adv; 2018 Jun; 2(11):1172-1179. PubMed ID: 29792312
[TBL] [Abstract][Full Text] [Related]
2. Children with HbSβ
Day ME; Rodeghier M; DeBaun MR
Pediatr Blood Cancer; 2018 Nov; 65(11):e27352. PubMed ID: 30094930
[TBL] [Abstract][Full Text] [Related]
3. Use of an automated pyrosequencing technique for confirmation of sickle cell disease.
de Martino CC; Alencar CS; Loureiro P; Carneiro-Proietti ABF; Máximo CA; Mota RA; Rodrigues DOW; Gaburo Junior N; Kelly S; Sabino EC;
PLoS One; 2019; 14(12):e0216020. PubMed ID: 31830127
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.
Yu TT; Nelson J; Streiff MB; Lanzkron S; Naik RP
Thromb Res; 2016 May; 141():35-8. PubMed ID: 26962984
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of a Sickle Cell Disease Cohort Within Electronic Health Records.
Michalik DE; Taylor BW; Panepinto JA
Acad Pediatr; 2017 Apr; 17(3):283-287. PubMed ID: 27979750
[TBL] [Abstract][Full Text] [Related]
6. Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.
Ilerhunmwuwa NP; Inyang L; Wasifuddin M; Aiwuyo H; Tahir M; Hakobyan N; Ankah P; Torere BE; Amaechi UM; Rayapureddy AK; Wang JC
Eur J Haematol; 2023 Oct; 111(4):611-619. PubMed ID: 37477175
[TBL] [Abstract][Full Text] [Related]
7. Sickle cell/β-thalassemia: Comparison of Sβ
Benites BD; Bastos SO; Baldanzi G; Dos Santos AO; Ramos CD; Costa FF; Gilli SC; Saad ST
Hematology; 2016 Dec; 21(10):623-629. PubMed ID: 27237196
[TBL] [Abstract][Full Text] [Related]
8. Impact of genotype on clinical course in sickle cell disease and the utility of neutrophil-lymphocyte ratio: a ten-year single-institution experience.
Mathavan A; Mathavan A; Mathavan M; Krekora U; Winer AJ; Altshuler E; Wnek R; Hones K; Thaper A; Artola R; Pucci L; Haley P; Carter D; Snead W; Manfrini D; Leach DF; DeLaune JD; Mandernach MW
Expert Rev Hematol; 2023; 16(9):701-710. PubMed ID: 37395002
[TBL] [Abstract][Full Text] [Related]
9. Intracranial Aneurysms in Sickle-Cell Disease Are Associated With the Hemoglobin SS Genotype But Not With Moyamoya Syndrome.
Birkeland P; Gardner K; Kesse-Adu R; Davies J; Lauritsen J; Rom Poulsen F; Tolias CM; Thein SL
Stroke; 2016 Jul; 47(7):1710-3. PubMed ID: 27301940
[TBL] [Abstract][Full Text] [Related]
10. How to reach rapid diagnosis in sickle cell disease?
Valavi E; Ansari MJ; Zandian K
Iran J Pediatr; 2010 Mar; 20(1):69-74. PubMed ID: 23056685
[TBL] [Abstract][Full Text] [Related]
11. Cerebral hemodynamics and metabolism are similar in sickle cell disease patients with hemoglobin SS and Sβ
Ikwuanusi I; Jordan LC; Lee CA; Patel NJ; Waddle S; Pruthi S; Davis LT; Griffin A; DeBaun MR; Kassim AA; Donahue MJ
Am J Hematol; 2020 Mar; 95(3):E66-E68. PubMed ID: 31814164
[No Abstract] [Full Text] [Related]
12. Hemoglobin to Hematocrit Ratio: The Strongest Predictor of Femoral Head Osteonecrosis in Children With Sickle Cell Disease.
Worrall D; Smith-Whitley K; Wells L
J Pediatr Orthop; 2016 Mar; 36(2):139-44. PubMed ID: 25705804
[TBL] [Abstract][Full Text] [Related]
13. Acute painful crises of sickle cell disease in Egyptian children: predictors of severity for a preventive strategy.
Al-Haggar M; Al-Marsafawy H; Abdel-Razek N; Al-Baz R; Mostafa AH
Int J Hematol; 2006 Apr; 83(3):224-8. PubMed ID: 16720552
[TBL] [Abstract][Full Text] [Related]
14. Adverse clinical and obstetric outcomes among pregnant women with different sickle cell disease genotypes.
Silva FAC; Ferreira ALCG; Hazin-Costa MF; Dias MLG; Araújo AS; Souza AI
Int J Gynaecol Obstet; 2018 Oct; 143(1):89-93. PubMed ID: 30030929
[TBL] [Abstract][Full Text] [Related]
15. Accessing primary care Big Data: the development of a software algorithm to explore the rich content of consultation records.
MacRae J; Darlow B; McBain L; Jones O; Stubbe M; Turner N; Dowell A
BMJ Open; 2015 Aug; 5(8):e008160. PubMed ID: 26297364
[TBL] [Abstract][Full Text] [Related]
16. The Sickle β-Thalassemia Phenotype.
Adekile AD; Akbulut N; Azab AF; Al-Sharida S; Thomas D
J Pediatr Hematol Oncol; 2017 Jul; 39(5):327-331. PubMed ID: 28060121
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of a computable phenotype to identify pediatric patients with leukemia and lymphoma treated with chemotherapy using electronic health record data.
Phillips CA; Razzaghi H; Aglio T; McNeil MJ; Salvesen-Quinn M; Sopfe J; Wilkes JJ; Forrest CB; Bailey LC
Pediatr Blood Cancer; 2019 Sep; 66(9):e27876. PubMed ID: 31207054
[TBL] [Abstract][Full Text] [Related]
18. Frequencies and phenotypic consequences of association of α- and β-thalassemia alleles with sickle-cell disease in Bahrain.
Abuamer S; Shome DK; Jaradat A; Radhi A; Bapat JP; Sharif KA; Al-Touq J; Al-Asheeri A; Al-Ajami A
Int J Lab Hematol; 2017 Feb; 39(1):76-83. PubMed ID: 27981798
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
Felice AE; McKie KM; Cleek MP; Marino EM; Kutlar A; McKie VC
Am J Hematol; 1987 Aug; 25(4):389-400. PubMed ID: 2441597
[TBL] [Abstract][Full Text] [Related]
20. Sickle cell disease as a cause of osteonecrosis of the femoral head.
Milner PF; Kraus AP; Sebes JI; Sleeper LA; Dukes KA; Embury SH; Bellevue R; Koshy M; Moohr JW; Smith J
N Engl J Med; 1991 Nov; 325(21):1476-81. PubMed ID: 1944426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
